|Articles|March 1, 2021

OneBio® Suite for Integrated Biologics Development

Author(s)Catalent

Catalent Biologics’ OneBio Suite is an integrated service that addresses the challenges facing biologic development companies to accelerate programs to clinic or market while leveraging proven biologics expertise. OneBio Suite reduces timelines, risk, and complexity by providing customers with a single contract, a global program manager, and an accelerated timeline from cell line to clinical supply with harmonized quality systems.
https://biologics.catalent.com/biologics/onebio-integrated-suite/

Catalent
14 Schoolhouse Road Somerset, NJ 08873 USA
Tel. +1.888.765.8846
solutions@catalent.com
www.catalent.com​


Related to this article

The BioPharm Brief: A $7 Billion Oncology Option Deal, a TL1A Pivot, and Oral Adalimumab Heads to the Clinic
Boehringer Ingelheim licenses six preclinical ADC and T-cell engager programs from Sino Biopharmaceutical in a deal worth up to $7 billion, Spyre Therapeutics drops anti-TL1A antibody SPY072 in rheumatic diseases after phase 2 misses and turns to hidradenitis suppurativa, and Biora Therapeutics gets ethics approval for a first-in-human trial of its BioJet oral adalimumab capsule.
The Promise of Microgravity for R&D and Manufacturing
As access to low Earth orbit expands, space-based research is opening possibilities in drug discovery, formulation, and manufacturing. In Part 1, the authors look at how microgravity changes biology and chemistry in ways that can’t be reproduced on Earth and where it fits from target discovery to life cycle management.